Recherche

We are pleased to announce that the Brussels University Hospital - Erasmus Hospital centre has obtained full ICARe-HF accreditation, an international distinction recognizing excellence in the management of heart failure. This accreditation was awarded based on the data submitted within the framework of the GRASP-HF 2025-2026 programme, with particular attention to quality-of-care indicators. It reflects the ongoing commitment of our teams to provide care that is rigorous, structured, and aligned with the best international practices.What this means for our healthcare professionals:This recognition highlights the daily work of multidisciplinary teams – physicians, nurses, and allied health professionals – involved in the management of heart failure. It reflects their expertise, coordination, and commitment to a continuous quality improvement approach.What this means for our patients:Patients benefit from an optimized care pathway, based on demanding international standards. This results in improved follow-up, more personalized care, and ultimately better clinical outcomes.What this represents for the hospital:This accreditation strengthens Hôpital Erasme’s position as a reference centre in cardiology, both nationally and internationally. It illustrates our commitment to promoting clinical excellence, innovation, and transparency in the evaluation of medical practice.This recognition is the result of collective work and a sustained commitment to high-quality care. Contact the Heart Failure Clinic

Lupus is an autoimmune disease, which can affect different organs and manifest very differently from one person to another. To better understand this condition, we interviewed Prof. Muhammad Soyfoo, Rheumatologist, and Prof. Frédéric Vandergheynst, Internal Medicine at H.U.B, both specialists in lupus.  Lupus: a disease with highly varied manifestations Lupus is an autoimmune disease. What is an autoimmune disease? Normally, our immune system acts as a shield: it protects us against viruses, bacteria, and other external threats. In an autoimmune disease, this system malfunctions. It can no longer distinguish between what is foreign and what belongs to our body… and starts attacking our own cells. This causes inflammation that can affect one or several organs, such as the skin, joints, or kidneys in the case of lupus. Each autoimmune disease is different, but all are based on the same principle: a defense system that targets the wrong thing. “Each patient is different,” explains Prof. Soyfoo. “Some only have skin involvement, others joint pain, and still others a systemic form affecting multiple organs, with very variable degrees of severity,” he adds. Among the most commonly affected organs are the skin, joints, and kidneys. The severity of the disease is often linked to kidney involvement, which can range from mild urinary abnormalities to rapidly progressive kidney failure requiring dialysis. However, lupus can sometimes present with rarer symptoms, such as neurological disorders, which may delay diagnosis because they are mistakenly interpreted as psychiatric conditions.  Despite this complexity, care is always personalized: “Each patient must be assessed globally and followed by a multidisciplinary team for optimal management,” emphasizes Prof. Vandergheynst.  A diagnosis that can take time The diagnosis of lupus takes on average 3 to 5 years. Yet, as Prof. Vandergheynst points out, the diagnosis itself is not necessarily difficult to establish… provided it is considered.“The main obstacle is thinking about the disease,” he explains. In other words, once lupus is suspected, medical tools generally allow confirmation fairly quickly. These include blood tests, which look for antibodies (proteins produced by the immune system) abnormally directed against the body, and sometimes tissue samples (from the skin or kidneys), analyzed under a microscope to better understand the involvement and choose the most appropriate treatment.  The main obstacles to diagnosing lupus Non-specific symptoms: fatigue, diffuse pain, sensitivity to sunlight, mouth ulcers… common and recurring signs in the general population that do not immediately suggest an autoimmune disease.   A disease that is still insufficiently known: by the general public, but also sometimes by primary care health professionals.  Symptoms that are sometimes minimized: particularly in young women, who are most affected, whose health condition is often attributed to stress or anxiety.   A fragmented view of the disease and its management: because it can affect multiple organs, lupus may be managed by several specialists (rheumatologists, nephrologists, dermatologists, internists, gynecologists) who, if they do not communicate with each other, work in silos and have only a partial view of the disease.  Image The need for coordinated and personalized care At the Brussels University Hospital (H.U.B), lupus care is based on collaboration between several specialists. The entry point varies depending on the symptoms: joint pain, skin rashes, neurological or general symptoms. Then, a multidisciplinary team coordinates to assess organ involvement and propose the most appropriate treatment. “We do not cure lupus, but we can control flares, limit damage, and sometimes achieve prolonged remission,” explains Prof. Soyfoo. Long-term follow-up also includes preventing complications related to treatments, such as the effects of corticosteroids on bones or metabolism, and specific aspects such as pregnancy planning. Image Lupus and pregnancy: a balance to build together Lupus mainly affects young women, often of childbearing age. The question of pregnancy is therefore central… and sometimes difficult to address. Yes, pregnancy is possible with lupus, but it must be carefully planned and closely monitored. What are the risks? When the disease is not well controlled, pregnancy may lead to: Lupus flares: recurrence or worsening of symptoms  Increased risk of preeclampsia: a complication where blood pressure rises and may affect the placenta  Placental problems: the placenta may function less effectively, which can slow the baby’s growth  In about 40% of cases, lupus is associated with antiphospholipid syndrome: the presence of autoantibodies (immune system proteins directed against the body) that increase the risk of recurrent miscarriages or thrombosis (formation of blood clots). Some patients must then take anticoagulants (blood-thinning medications) during pregnancy, requiring close monitoring. Treatments to be adjusted Not all medications used for lupus are compatible with pregnancy. Some are teratogenic: they can cause malformations in the baby. Others may reduce fertility. It is therefore important to plan the pregnancy and adjust treatments in advance. Essential specialized follow-up Coordination between rheumatologists, internists, and obstetricians is crucial to manage treatments safely and ensure a safe pregnancy and delivery for both mother and baby. An intimate decision… sometimes difficult to support Discussing the desire to have a child can be complex. For patients, it can be a source of concern. For doctors, it involves significant responsibility: “We are not here to prevent patients from living their lives. But in some situations, giving our approval — or on the contrary advising against pregnancy — represents an important responsibility,” says Prof. Vandergheynst. In some cases (active disease, severe kidney involvement), pregnancy is strongly discouraged. In others, the decision is more nuanced. The goal is never to punish or make anyone feel guilty, but to enable an informed choice, taking into account risks and the patient’s life plan. Promising advances Treatments for lupus have evolved considerably in recent years. Personalized medicine and biotherapies are opening new perspectives, for example: Hydroxychloroquine: a long-standing, low-cost treatment that effectively reduces the frequency of flares. Targeted biotherapies: medications such as anifrolumab (Saphnelo) or belimumab (Benlysta) act on specific molecules involved in the disease, reducing the use of corticosteroids and improving quality of life. Precision medicine: in the future, treatments could be adapted to the biological profile and molecular expression of each patient, rather than to the disease in general. Personalized medicine is not yet standardized, but it offers great promise with more precise and effective treatments and fewer side effects. Non-invasive biomarkers to monitor kidney involvement could also reduce the need for frequent biopsies.  The impact of lupus on daily life Beyond physical symptoms, lupus profoundly affects daily life. Chronic fatigue, pain, limitations in certain physical activities, and constraints related to sun exposure can be very restrictive. The treatment itself, particularly corticosteroids, can alter physical appearance and affect body image. Lupus also has psychological, social, and professional consequences. Patients may have to reduce their working hours or modify their life plans, including pregnancy planning. Their sexual and emotional life may also be affected by the disease. Listening, therapeutic education, and comprehensive support are essential to help patients cope with these aspects. A complex disease, but one that can be treated Lupus is a complex, variable disease that is often difficult to diagnose. Successful management relies on multidisciplinary care, personalized treatments, and comprehensive patient support. Thanks to recent advances in biotherapies and precision medicine, new perspectives are emerging to improve quality of life and enable everyone to live fully despite the disease.  Interview with our experts Need to contact our specialists? To contact the Rheumatology Department, please send an email to Cons [dot] Rhumato [dot] erasme [at] hubruxelles [dot] beTo contact the Internal Medicine Department, please send an email to Cons [dot] MedIntern [dot] erasme [at] hubruxelles [dot] be

On the occasion of World Parkinson’s Disease Day on April 11, 2026, Dr. Vincent Leclercq, neurologist and specialist in movement disorders at H.U.B, sheds light on the current realities of the disease and the importance of appropriate care. Parkinson’s disease is often mentioned, sometimes feared, but still poorly understood. Tremors, a disease affecting only the elderly… misconceptions are numerous. Yet knowledge and treatments have evolved considerably in recent years.On the occasion of an information day for patients organized this Saturday, April 11, 2026, Dr. Vincent Leclercq, neurologist and specialist in movement disorders at the Movement Disorders Clinic of H.U.B, sheds light on the current realities of the disease and the importance of appropriate care. A disease that does not only affect the elderly Contrary to popular belief, Parkinson’s disease is not only a disease of older people.“It is primarily an adult disease,” explains Dr. Leclercq.On average, the first symptoms appear around the age of fifty. However, early-onset forms exist, sometimes beginning in one’s twenties, as well as diagnoses at 80 or 90 years old.The disease affects both men and women. In Belgium, it concerns approximately 5% of the population, making it a common condition and a real public health issue. Early warning signs Parkinson’s disease is not limited to tremors. Three major so-called “cardinal” symptoms should raise attention:Resting tremor, usually affecting one hand at first, on one side, occurring when the hand is at rest.Bradykinesia (slowness of movement): movements become slower and less precise, handwriting changes, difficulty buttoning a shirt, loss of fine dexterity.Gait disturbances: walking slows down, steps become smaller, the body may lean forward.The disease also includes many non-motor symptoms, often less visible yet highly disabling:Digestive or urinary disordersDifficulty concentratingSlowed thinkingSwallowing disordersThese symptoms are sometimes the main complaint of patients. In case of doubt, referral to a specialized consultation is essential. Image A clinical diagnosis, sometimes made at the first consultation Parkinson’s disease is one of the few neurological diseases whose diagnosis is primarily clinical.It is based on observation of symptoms and neurological examination. Additional tests may be performed in case of doubt but are not systematic. The announcement of the diagnosis is often a shock. “It is a moment that disrupts the patient’s life,” emphasizes Dr. Leclercq.The team ensures that the diagnosis is delivered with sufficient time to answer questions, allow emotional expression, and lay the foundations for reassuring care.An essential message must be heard: it is possible to live autonomously with proper care. Image Care adapted to each stage of the disease In the early stagesTreatment mainly relies on dopatherapy: supplying the brain with the dopamine it lacks.Results can be spectacular:Significant improvement in symptomsPreserved quality of life for several yearsPatients may remain stable for a long time, with follow-up consultations mainly aimed at adjusting treatment.In more advanced stagesAfter 5 to 10 years, medication effectiveness may fluctuate. “On” periods (when treatment works well) alternate with “off” periods.Advanced therapies may then be proposed:Subcutaneous pump delivering continuous dopamine via a small needleDigestive pump administering dopamine directly into the stomach via a tube placed endoscopicallyDeep brain stimulation: a neurosurgical procedure implanting electrodes in deep brain structures, connected to a generator under the skin, similar to a pacemaker. This continuous stimulation compensates for deficient electrical activityThese solutions often allow better stability and significantly improve quality of life. Image An unpredictable progression, but structured support Parkinson’s disease is a neurodegenerative disease.Its progression varies greatly from person to person. Some patients progress very slowly, others more rapidly. To date, it is not possible to precisely predict the rate of progression.Loss of autonomy may occur over time, particularly due to:Gait disordersRisk of fallsSwallowing difficultiesHowever, things have changed.In the past, complications (falls, aspiration, infections) often led to death. Today, thanks to appropriate and multidisciplinary care, people no longer die from Parkinson’s disease when it is properly managed.To preserve autonomy as long as possible and prevent complications, the consultation works closely with:PhysiotherapistsSpeech therapistsOther specialized professionals An information day to understand and exchange “This event is important because the disease remains poorly known and is often confused with other neurodegenerative conditions. Because 30-minute consultations every three months are not enough to cover all aspects of the disease. Because relatives and caregivers do not always have the opportunity to express their questions or difficulties,” explains Dr. Leclercq.The program included:Thematic sessions led by various speakersClear and accessible explanationsMoments for discussion and Q&AA space for open, stigma-free dialoguePromoting expertise and strengthening connectionsBeyond informing patients and the general public, this day also highlights the expertise of the specialized Parkinson’s consultation:An experienced teamA multidisciplinary approachMastery of advanced therapiesHuman and individualized support for patients and their relativesBecause better understanding the disease already helps to live better with it. And because a well-informed and well-supported patient remains an active participant in their care journey. Together, let’s advance the understanding and management of Parkinson’s diseaseFor any questions, you can contact the neurology consultation secretariat by email at secmed [dot] neuro [dot] erasme [at] hubruxelles [dot] be (secmed[dot]neuro[dot]erasme[at]hubruxelles[dot]be)  Discover the Clinic Dr Vincent Leclercq Neurologist and specialist in movement disorders.

June is Infertility Awareness Month. On this occasion, the H.U.B is launching a new campaign and offering a wide range of activities designed to inform and engage both the public and healthcare professionals on the issues surrounding infertility and its treatment. Image Infertility now affects a growing number of people in Belgium, with approximately one in six couples experiencing fertility difficulties during their lifetime. Still often considered a taboo subject, infertility can have a profound emotional, social, and psychological impact. Its causes are varied, affecting both women and men, and in some cases remain unexplained. Despite major medical advances, access to information and support remains unequal. Raising awareness about infertility is essential to break the silence and better support those concerned.For this reason, during Infertility Awareness Month, the experts of the H.U.B Fertility and MAR Clinic are mobilising and offering a series of activities for the public and healthcare professionals. These events will provide an opportunity to learn more about infertility, the diseases that can affect fertility (cancer, endometriosis, PCOS, etc.), the available treatments and care pathways, but above all to share personal journeys and stories, helping those experiencing difficulties conceiving to feel supported and less alone. Image Infertility Awareness Month Programme Thursday, June 11, 2026Information and Awareness BoothThe teams from the H.U.B Fertility and MAR Clinic will welcome you to answer your questions and provide information on all the options available to support people experiencing difficulties conceiving.At the stand, you will find:A space dedicated to family planning journeysInformation about fertility preservationAn educational area on the female cycle and fertilityInformation about male fertilityInformation on preimplantation genetic diagnosis and genetic diseasesA podcast corner featuring patients' testimonials on their fertility journeyInformation about the different types of donorsResources and practical information about the care services available at H.U.BA quiz to test your knowledgeWhere? Main hall of Erasme Hospital, ground floorWhen? June 11th, 2026, from 10:00 a.m. to 4:00 p.m.Free and open to everyone. Image Thursday, June 18, 2026Symposium for Gynaecologists and General PractitionersAs a leading academic hospital, the H.U.B is organising a symposium aimed first at exchanging with gynaecologists on personalised approaches in assisted reproduction, and secondly with general practitioners on the latest developments in first-line infertility care.Date: Thursday, June 18, 2026Schedule for gynaecologists: 2:30 p.m. – 7:30 p.m.Schedule for general practitioners: 6:30 p.m. – 9:30 p.m.Location: Museum of Medicine, Erasme Campus – Place Facultaire, Route de Lennik 808, 1070 Brussels, BelgiumFree event, but registration is mandatory. Accreditation request pending.Registrations close on June 11, 2026, at 5:00 p.m. Programme for gynaecologists Programme for general practitioners Wednesday, June 24, 2026Healthcare Professional–Patient WorkshopsWorkshop 1 – What diet should you adopt to support fertility?Led by Dr Pascale Chasseur, Endocrinologist, and Dr Isabelle Dupond, Gynaecologist.Workshop 2 – How can you experience sexuality during an MAR journey?(Workshop reserved for men)Led by Dr David Pening, Gynaecologist and Andrologist, and Clarisse André Portella, Sexologist.Workshop 3 – What impact does Polycystic Ovary Syndrome (PCOS) have on fertility?Led by Dr Mélodie Vander Borght, Gynaecologist, and Victoria Di Pietrantonio, Gynaecologist specialised in endocrine disorders. Date: Wednesday, June 24, 2026, from 6:00 p.m. to 8:00 p.m.Participation by invitation only.Free registration, but mandatory. Image Wednesday, July 1, 2026INTERACTIVE WEBINARDeciding Without a Magic Wand: Moving Forward Even When You Don’t Feel ReadyHosted by Dr Catherine Houba, Gynaecologist and Director of the H.U.B Fertility and MAR ClinicAre you wondering whether there is such a thing as the “right time” to have a child? This webinar is designed for anyone reflecting on their parenthood journey without certainty or a perfect timeline. Through an open and honest approach, we will challenge common misconceptions about maturity and the ideal moment to become a parent, while distinguishing between what is within your control… and what is not.You will discover practical ways to take action today, at your own pace and according to your personal situation. The goal: to leave feeling informed, reassured, and equipped with a concrete first step towards your own decision.Topics covered include:The impossibility of waiting until you feel “ready”Why the perfect moment does not existThe generational impact of contraceptionThe “myth of maturity”What we can decide, and what we cannot controlRelationships and emotional lifeBiologyCareerFinancial and material conditionsTaking back the power to actMicro-decisionsEgg and sperm preservationSolo parenthood: framework, benefits, and realitiesChoosing not to have children: a legitimate decision that also deserves supportQuestions & AnswersWhen? July 1, 2026, from 6:00 p.m. to 7:15 p.m.Participation in this webinar is free and accessible via this link. With the support of

1. Undertaking of accessibility The HUDERF hospital undertakes to make its website accessible in accordance with the Belgian law of 19 July 2018 transposing European Directive 2016/2102 on the accessibility of the websites and mobile applications of public sector bodies. This accessibility statement applies to the website: https://www.erasme.be/en  2. Compliance status The website is partially compliant with European standard EN 301 549 due to the non-compliances listed hereunder. 3. Non-accessible content The problems identified at the time of automatic audits are the following:3.1 Non-compliances – Colour contrast (WCAG 1.4.3)Numerous text elements present an insufficient colour contrast in regard to the minimum requirements (4.5:1 for normal text, 3:1 for large text). The elements concerned are:Principal navigation links ("About", "News", "Press", "My HUB", "Jobs")Action buttons ("Emergencies”, "My appointments", "Patients and loved ones", "Professional Space")“See all news” link and “All events” link”“Make a donation” linkNews dates  (<time> elements)Subheading text (span) on hero blocks/highlightingLinks to social networks (Facebook, LinkedIn, YouTube)3.2 Non-compliances – Accessible names and labels (WCAG 4.1.2)Several interactive elements do not have a name that is accessible for assistance technologies:Close button (btn--close): no aria-label or text contentMobile menu button (nav--menu-toggle): no accessible name"Overlink" links (a.overlink): links with valid href but without text content or aria-label — 3 occurrences identified by LighthouseAnchor #main-content: presents an id but no href or text3.3 Non-compliances – Parsing / Duplicate identifiers (WCAG 4.1.1)Several id attributes are duplicated on the page. This can disrupt the assistance technologies: id="block-erasme-theme-dropdown-language" — duplicate valueid="block-erasme-donation" — duplicate valueid="block-erasme-rdv" — duplicate value3.4 Non-compliances – Title structure (WCAG 1.3.1)The title hierarchy is not incorporated logically in certain page sections:  An h3 element (h3.highlighting--title) appears without a preceding h2 in  its section,  creating a level skipA paragraph containing text in <strong> ("Erasme") should use a title tag if this content plays the role of section title3.5 Non-compliances – Reflow (WCAG 1.4.10)Certain fixed content or stickies can cause a two dimensional flow when the page is zoomed to 400%:Manage content button (klaro_toggle_dialog): position:fixedHeader sticky (#sticky / .big-header-wrapper): position: fixedOverlay video (.reveal-overlay): position: fixed 4. Drawing up of statement This statement was drawn up on the basis of an automatic evaluation effected on 14 April 2026, with the assistance of the following tools:  Google Lighthouse 13.0.2 (emulation desktop, Chromium 146.0.0.0) – Accessibility score: 88/100HTML_CodeSniffer – Standard WCAG2AA – 33 errors, 40 alertsThis audit constitutes a simplified analysis. It only covers a subset of the EN 301 549 standard criteria and does not provide a basis for declaring the site fully compliant. Only an in-depth audit carried out by an accessibility expert would permit this level of compliance.   5. Contact and reporting If you encounter an accessibility problem on the www.erasme.be website, you can contact the responsible team: Using the contact form available on the website : https://www.erasme.be/en/contact-erasme By post: Hôpital Erasme, Route de Lennik 808, 1070 AnderlechtWe undertake to respond to your request within a reasonable time.  Complaints procedureIf you do not receive a satisfactory response from us you can submit a complaint to the control body designated by the royal decree of 5 September 2019:  SPF Stratégie et Appui (BOSA)Address : boulevard Simon Bolivar 30, bte 1, 1000 BruxellesWebsite : https://bosa.belgium.be/en/complaints Recours auprès du Médiateur fédéralSi la réponse du SPF Stratégie et Appui ne vous satisfait pas non plus, vous pouvez vous adresser au Médiateur fédéral :Médiateur fédéralAdresse : rue de Louvain 48, bte 6, 1000 BruxellesE-mail : contact [at] federalombudsman [dot] be (contact[at]federalombudsman[dot]be) Site web : https://www.mediateurfederal.be/en/homepage   6. Proposed alternatives For any content or functionality of the www.erasme.be website that is not yet accessible, you can contact our team to obtain an accessible alternative:Using the contact form: https://www.erasme.be/en/contact-erasme By post: Hôpital Erasme, Route de Lennik 808, 1070 AnderlechtWe undertake to provide you with information in an accessible format and within a reasonable time.  The content in question that does not yet comply is:  Navigation elements with insufficient colour contrastLink buttons with no accessible nameSections with incorrect title hierarchy 7. Improvement plan The non-compliances identified at the time of the audit of 14 April 2026 shall be subject to progressive corrections. The improvements foreseen concern in particular:The correction of insufficient contrast ratios on navigation elements, action buttons, dates and linksThe addition of accessible names (aria-label) on buttons and links without perceptible textThe deletion of duplicate id attributes in the source codeThe correction of the title hierarchyThe review of fixed content to avoid a two dimensional flow when making a major zoom.  These corrections will be implemented at the time of upcoming site developments.   8. Statement updating This statement will be updated no later than at the time of the next significant website revision or at the time of a new accessibility audit.  Last updated on: 14 April 2026.

The Fertility and Medical Assisted Reproduction (MAR) Clinic of the H.U.B invites you on June 18, 2026 to a symposium dedicated to current perspectives in fertility care Image On the occasion of Infertility Month, the Fertility and MAR Clinic of the H.U.B is running a communication campaign throughout the month of June entitled "Your Fertility, Your Story".As part of this campaign, numerous activities are being organized to raise awareness and inform the public and healthcare professionals about the challenges of infertility and its management. Program 2:30 PM – Welcome & coffeeInformal networking moments with the Erasmus MAR Center team.3:00 – 3:10 PM – Personalizing patient intake: Mindoo, AI supporting the MAR pathway How an AI agent improves information, reduces anxiety, and facilitates access to care.Presentation and Q&A with Dr Catherine HoubaDirector of the Fertility Clinic of the H.U.B3:20 – 3:40 PM – AMH: How to explain it simply and effectively to patientsInterpretation, limitations, key messages, and pitfalls to avoid in first-line consultation.Presentation and Q&A with Prof Anne DelbaereHead of the H.U.B epartment of Obstetrics and Gynecology 3:50 – 4:10 PM – Endometriosis & fertility: what to tell patients, when to refer?Actual impact on fertility, indications for specialized care, optimal timing.Presentation and Q&A with Dr Agathe RabattuGynaecologist at the Fertility and Endometriosis Clinics of the H.U.B4:20 – 4:40 PM – Embryo selection by PGT-A: indications, limitations, and controversiesA clear update to guide discussions with patients.Presentation and Q&A with Dr Isabelle DupondGynaecologist at the Fertility Clinic of the H.U.B4:50 – 5:10 PM – IVF: how to reduce side effects and improve patient experienceNew strategies, better tolerated protocols, personalization of stimulation.Presentation and Q&A with Prof Fabienne DevrekerGynaecologist at the Fertility Clinic of the H.U.B5:20 – 5:40 PM – Late motherhood: what options can be offered today?Fertility preservation, alternatives, management of pregnancies after age 38.Presentation and Q&A with Dr Soraya AmirgholamiGynaecologist at the Fertility Clinic of the H.U.B6:30 – 7:30 PM – Dinner cocktail Registration Practical information Date: Thursday, June 18, 2026, from 2.30pm to 7.30pmLocation: Museum of Medicine, Erasme Campus – Place Facultaire, Route de Lennik 808, 1070 Brussels, Belgium. AccessFree event, but registration is mandatory – Accreditation request in progress.This is an in-person event; no remote participation will be available.Registration closes on June 11, 2026 at 5:00 PM. Our speakers Dr. Catherine Houba Director of the H.U.B Medical Assisted Reproduction (MAR) Clinic since March 2024, specializing in the management of infertility. Her clinical and scientific work focuses on ovarian insufficiency and its therapeutic options, particularly oocyte donation. Dr. Houba has a particular interest in the medical, ethical, and human aspects of this care. Her work also includes fertility preservation. She favors a multidisciplinary and personalized approach based on evidence-based medicine. Anne Delbaere is an obstetrician-gynecologist specializing in reproductive endocrinology and assisted reproductive technology. She directed the Fertility Clinic of Erasmus Hospital from 2002 to 2024. Since 2020, she has been Head of the Department of Obstetrics and Gynecology at the Brussels University Hospital (H.U.B), covering the Erasmus Hospital and the Jules Bordet Institute sites. She is a professor of gynecology and a clinical supervisor at ULB. Dr. Agathe Rabattu A physician working in a fertility clinic since 2024, she supports intended parents in their desire to have a child by offering a personalized approach centered on their family project. Her work includes a comprehensive fertility assessment and the implementation of tailored strategies to optimize the chances of conception. She places particular importance on listening, providing clear information, and supporting patients throughout the development of their parental plans. She is also developing specific expertise in fertility preservation, particularly for patients with endometriosis, in order to anticipate the impact of the disease on reproductive potential and to offer solutions adapted to their life plans. Pr. Fabienne Devreker Specialist physician in fertility medicine and support for reproductive care pathways. Prof. Devreker is dedicated to supporting patients in their parenthood journey, using a personalised and innovative medical approach. Her expertise includes the management of complex infertility cases, the use of gamete donation, as well as advanced techniques such as Preimplantation Genetic Diagnosis (PGD), in order to offer solutions tailored to the specific needs of each individual or couple. She also pays particular attention to inclusivity in her practice, developing specific expertise in the care of transgender individuals. Her approach is based on attentive listening, scientific rigor, and the adaptation of protocols to ensure optimal care, in line with each patient’s values and expectations. Image Dr. Isabelle Dupond Graduated in Obstetrics and Gynecology in 2006, Dr. Dupond has been working at the Erasmus Fertility Clinic ever since, first as a resident and then as a consultant. She divides her professional activity into two main areas: private practice in obstetrics and gynecology, and fertility care at Erasmus Hospital, with a particular focus on preimplantation genetic diagnosis and social ovocyte cryopreservation. Dr. Soraya Amirgholami Resident at the Fertility Clinic since 2021, I specialize in the overall management of infertility, with a particular focus on oocyte donation, for which I am part of the medical coordination team. My scientific work focuses on strategies to improve success rates in oocyte donation cycles, as well as the implementation of more “patient-friendly” frozen embryo transfer protocols. In the era of AI and social media, I am particularly interested in the social, ethical, and human challenges surrounding our medical practices. With the support of

The Fertility and Medical Assisted Reproduction (MAR) Clinic of the H.U.B invites you on June 18, 2026 to a symposium dedicated to current perspectives in fertility care Image On the occasion of Infertility Month, the Fertility and MAR Clinic of the H.U.B is running a communication campaign throughout the month of June entitled "Your Fertility, Your Story".As part of this campaign, numerous activities are being organized to raise awareness and inform the public and healthcare professionals about the challenges of infertility and its management. Program 6:30 – 7:30 PM – Dinner cocktail7:30 – 8:00 PM – What assessment for an infertile couple?Presented by Dr Noémie VancoppenolleGynaecologist at the Fertility Clinic of the H.U.B8:00 – 8:15 PM – What is the role of imaging in this assessment?Presented by Dr Noé MoutardGynaecologist at the Fertility Clinic of the H.U.B8:15 – 8:30 PM – Questions & discussion with speakers8:30 – 9:00 PM – Endocrine disruptors and fertility: how to address the topic in preconception care?Presented by Dr Jean-François SimonGynaecologist at the Fertility Clinic of the H.U.B9:00 – 9:30 PM – Male sexual disorders in MAR: what management?Presented by Dr David PeningGynaecologist at the Fertility Clinic of the H.U.B Registration Practical information Date: Thursday, June 18, 2026Location: Museum of Medicine, Erasme Campus – Place Facultaire, Route de Lennik 808, 1070 Brussels, Belgium. AccessFree event, but registration is mandatory – Accreditation request in progress.This is an in-person event; no remote participation will be available.Registration closes on June 11, 2026 at 5:00 PM. Our speakers Image Dr. Noémie Vancoppenolle Specialist physician in gynecology, trained at ULB, I received in-depth, diverse, and rigorous training across three major hospital institutions in Brussels. I currently work in fertility at Erasmus Hospital, where I support patients through their assisted reproductive journeys, including within the gamete donation team. Young, dynamic, and motivated, my approach is both rigorous, personalized, and caring for each patient. Image Dr. Noé Moutard Obstetrician-gynecologist, trained in Paris and Brussels, Dr Noé Moutard specializes in assisted reproductive technology. He has been affiliated with the fertility clinic at Erasmus Hospital since 2017. He holds an interuniversity diploma in assisted reproduction and operative hysteroscopy. He works closely with the endometriosis clinic and offers care pathways for infertile patients with gynecological surgical conditions. Image Dr. David Pening David Pening graduated as a Medical Doctor in 2013 and in Obstetrics and Gynaecology in 2018 from Université Libre de Bruxelles. In the field of ART, he did training in Fertility at Brussels IVF. His clinical and research interests are in Andrology, as he graduated in Andrology from Université de Lille in 2021 and does his PhD on sperm capacitation at ULB. He obtained an Executive Master in Management of Healthcare Institutions from Solvay Brussels School of Economics and Management in 2025. He is currently PHU at H.U.B Erasmus Hospital and since 2026, honored to be President of the Belgian Society for Reproductive Medicine (BSRM). With the support of

On this World Obesity Day, Professor Jean-Charles Preiser, from the Department of Internal Medicine and expert within the team of the Integrated Obesity Centre at H.U.B, explains the new approaches to managing this chronic disease. Prevention, Comprehensive Assessment and a Tailored Approach At the Integrated Obesity Centre of H.U.B, Professor Jean-Charles Preiser from the Department of Internal Medicine sees patients with very different profiles. Some come because of high blood pressure, others for poorly controlled diabetes, joint pain, or sleep disorders. And then there are those who simply walk in and say, “Doctor, I have a problem with my weight.”“My role,” he explains, “is first to have a global vision. Obesity does not affect just one organ. It can involve the heart, the liver, the joints, the metabolism, and sleep.”Behind the word “obesity” there is often a silent accumulation of complications: diabetes, hypertension, sleep apnoea, fatty liver disease, certain cancers. Sometimes already present. Sometimes still invisible.An assessment to understand, not to judgeThe first step is not treatment, but assessment. Blood tests to detect sometimes asymptomatic diabetes. Blood pressure measurement. Sleep evaluation. Screening for liver damage, sometimes completely silent.“We systematically investigate potential complications. Not to make the file heavier, but to guide treatment,” emphasises Professor Preiser.Today, management has evolved. The options are numerous: structured dietary support; psychological support (particularly in cases of eating disorders); drug treatments; and even bariatric surgery for the most severe cases.“A few years ago, surgery represented a significant share of referrals. Today, drug treatments occupy an increasing place. About one patient out of two benefits from them. Surgery concerns a minority of cases, around 20%,” says Professor Preiser.New generations of medications, notably incretin analogues (GLP-1, GIP), have changed the therapeutic landscape. They are part of the current arsenal, with significant results in many patients. But they are neither automatic nor universal. Their cost remains high and reimbursement is limited to certain situations, particularly in cases of poorly controlled diabetes.“There is no single treatment. There is a strategy tailored to each patient,” he insists.“It’s all because of your weight”: moving beyond shortcutsMany patients arrive with a sense of exhaustion: after hearing consultation after consultation that all their symptoms are related to their weight.Dr Preiser nuances this: “Yes, obesity increases the risk of many complications. But the probability of developing a disease is not strictly proportional to the degree of obesity.”Some people living with severe obesity for years present few complications. Others, with more moderate obesity, develop early metabolic or cardiovascular problems.Why? Genetic background plays a major role. Family history — heart attack, stroke, liver disease, diabetes — guides the level of risk. The association with other factors, such as alcohol consumption or smoking, also changes the picture.The message is clear: obesity is an important risk factor, but it does not explain everything. Each situation deserves individual analysis.A new definition: looking at fat mass, not only weightSince 2025, the definition of obesity has evolved: it is no longer only total body weight that matters, but the proportion of fat mass.“The objective is not to make patients lose muscle or water. What we aim for is a reduction in fat mass while preserving muscle mass,” Professor Preiser reminds us.This approach is particularly important in geriatrics, where muscle loss can worsen frailty and increase the risk of falls. Hence the importance of sufficient protein intake and adapted physical activity, even during drug treatment.Men and women: different risksComplications are not identical depending on sex. In women, obesity can lead to fertility disorders or polycystic ovary syndrome. After menopause, the risk of breast cancer increases in cases of obesity. Knee pain is also more frequent.In men, there is a greater accumulation of cardiovascular risk factors and a higher frequency of certain digestive cancers and prostate cancer.In both cases, screening remains essential. Treating obesity after cancer, for example, can help reduce the risk of recurrence.Increasingly younger patientsThe most striking evolution in recent years concerns the age of patients.“Obesity is increasing among children and adolescents, often against a background of socio-economic and cultural factors. Sedentary lifestyles, accentuated by the COVID period, have played a role. Many obese young people become obese adults,” laments Professor Preiser.Some consult spontaneously, with a desire to understand and act early.Other situations are emerging: women undergoing medically assisted reproduction, where obesity management and fertility treatment occur in parallel. After childbirth, priority may shift to the newborn, pushing maternal health into the background. “These are human realities that must be integrated into care,” the geriatrician points out.The sensitive issue of relapseObesity is a chronic disease. Like any chronic disease, it can lead to relapse.After surgery, very rapid weight loss can lead to deficiencies or malabsorption problems, and weight regain may occur. With dieting alone, the “yo-yo effect” remains the typical failure when recommendations are not adapted to lifestyle or when an eating disorder is not addressed.Regarding recent medications, long-term data are still limited. Doses are adjusted progressively according to individual response and side effects. Discontinuation must be gradual, accompanied by increased physical activity and sufficient protein intake to preserve muscle mass. Strategies can be combined: drug treatment before or after surgery, reintroduction in case of weight regain.“The key is continuity of follow-up,” insists Professor Preiser.Changing the way we look at obesity and its managementSome patients arrive with a clear idea: “I want surgery” or “I want this new medication.” Sometimes they leave with a different proposal after a full assessment.“Our role is to explain that several options exist and that the choice depends on the overall medical evaluation,” Professor Preiser recalls.Obesity is not just a number on a scale. Nor is it a personal failure. It is a chronic, multifactorial disease, influenced by genetics, environment, lifestyle, and social context.Treating it is not only about losing weight. It is about preventing complications, preserving quality of life, rebuilding self-esteem, overcoming emotional wounds and destructive habits and, in the most severe cases, maintaining autonomy.For those living with obesity — or supporting a loved one affected by obesity — the message may be this: solutions exist. They are multiple, personalised, and evolving. And above all, they are built together with the patient, step by step, throughout their care pathway and life journey.Multidisciplinary team-based careAt H.U.B, care is multidisciplinary: internists, endocrinologists, dietitians, psychologists, gastroenterologists, hepatologists, cardiologists, and sleep specialists. This network organisation prevents patients from facing a complex disease alone. Contact the Obesity Centre Pr. Jean-Charles Preiser Also read: The role of dietetics in the multidisciplinary management of obesityIngrid Hanson, a dietitian accredited by the Federal Public Service for Public Health at the Integrated Obesity Center of H.U.B., explains the delicate issue of nutrition for patients who wish or need to lose weight. Discover the interview. 

On the occasion of World Obesity Day, Ingrid Hanson, a dietitian accredited by the Federal Public Service for Public Health at the Integrated Obesity Center of H.U.B., explains the delicate issue of nutrition for patients who wish or need to lose weight. A personalized and Sustainable Care What is the role of a dietitian in the management of a patient with obesity? How does this differ from that of a nutritionist?The Integrated Obesity Center supports patients who are overweight or living with obesity in their weight loss journey, whether through lifestyle modifications alone or with the help of medication or surgical techniques.My role within the team is to support patients in these three approaches throughout the entire proposed program, aiming for comprehensive and sustainable care.This includes assessing their eating habits, implementing personalized nutritional follow-up adapted to their treatment, providing therapeutic education, and offering motivational support. I work closely with the multidisciplinary team (surgeons, endocrinologists, gastroenterologists, internist, physician nutritionist, and psychologists) to offer a complete and situation-specific approach.To answer your question regarding the approach of nutritionists, it is important to clarify that the term “nutritionist” is not legally protected in Belgium.At the CIO, we are 4 dietitians and we also collaborate with a general practitioner who is a nutritionist. This is important to specify because the term “nutritionist” does not carry much meaning, as it is not protected in Belgium, unlike the title “dietitian.” The title of Dietitian is legally protected and defined by the Royal Decree of February 19, 1997. In addition, accreditation granted by the Federal Public Service for Public Health is mandatory to demonstrate that dietitians meet the required standards to practice (education, internships, continuing professional development, compliance with professional regulations) and to guarantee patients a professional, high-quality service.The physician nutritionist (or holder of the interuniversity certificate in clinical nutrition) has a complementary approach to that of dietitians.At the Integrated Obesity Center, the physician nutritionist mainly addresses the medical and metabolic aspects: making diagnoses and prescribing tests and medical treatments.As a dietitian, I specialize in daily nutritional and micronutritional support. The era of rigid meal plans is over! Our support is designed to be practical, personalized, and applicable to everyday life. This is even more relevant with the arrival of new drug treatments, which require regular monitoring of muscle mass, protein intake, and vitamin and mineral intake.Our goal is to support all patients engaged in weight loss over the long term, help them gradually modify their eating behaviors through concrete and realistic objectives, limit the risk of nutritional deficiencies, overcome barriers, and build a more peaceful relationship with food.How do you adapt dietary advice to different patient profiles?Each patient is unique, which is why adaptation is central to our work. Our patients follow different care pathways and may benefit from medication, an intragastric balloon, or surgery to support weight loss. Management is progressively tailored on a case-by-case basis, including possible texture adaptations, adjustments in portion sizes, and advice to relieve treatment side effects.To personalize care, I consider age, sex, family and social context, eating habits and preferences, level of physical activity, and any associated medical conditions.For adults followed at the CIO, support focuses on daily organization (meal timing, help with menu planning, portion sizes, incorporating moments of physical activity), managing meals at work, understanding hunger and satiety signals, and ensuring long-term sustainability of changes.Advice may also vary according to sex, particularly to account for hormonal differences, life stages such as menopause, and specific individual issues.For patients with comorbidities such as diabetes, hypertension, or metabolic disorders, I work closely with the medical team to provide targeted, safe, and personalized nutritional recommendations.The objective always remains the same: within the framework of a chronic disease, where the risk of relapse is real regardless of the treatment implemented, to propose adapted, realistic nutrition compatible with daily life in order to promote sustainable changes and improve quality of life.What are the most common dietary obstacles you observe among your patients and how do you help them overcome them?Obesity is recognized as a multifactorial disease linked to overall lifestyle. Dietary obstacles are often multiple and intertwined.On an emotional level, many patients exhibit eating behaviors influenced by stress, fatigue, anxiety, or negative emotions. Collaboration with psychologists is essential here. Our role is to help patients better identify their emotional triggers, for example through a food diary, and to develop alternative strategies.On a social level, professional constraints, irregular schedules, meals eaten on the go, lack of time to cook, and social pressure play a significant role. I support patients by working with them to find practical, realistic solutions adapted to their lifestyle to facilitate daily meal organization.Economic factors are also decisive. Some patients have limited food budgets, which may hinder access to food perceived as healthier. I analyze with them the products they commonly purchase and the stores they frequent to identify healthier yet equally affordable alternatives. I also adapt menus and meal preparation techniques accordingly.Regarding differences between men and women, women seem more often confronted with mental load, emotional management, and guilt related to food, whereas men more frequently face barriers related to large portions, alcohol consumption, or eating out. Due to family organization, many women also appear to have more difficulty establishing regular physical activity.These are, of course, general trends, and each situation remains unique. In all cases, the support aims to identify and gradually overcome these obstacles through a compassionate approach, building concrete, personalized, and sustainable solutions with each patient.Why is weight stabilization often more difficult than initial weight loss?We must never forget that obesity is a chronic disease of adipose tissue. Losing weight is often easier than maintaining it, because the body naturally resists weight loss and seeks to return to its initial balance. This applies to all treatments: lifestyle changes, intragastric balloon placement, medication, and surgery.Stabilization therefore requires long-term support and continuous adaptation. Above all, what matters is preventing health problems related to excess weight, even if many patients will have to grieve the idea of their ideal weight.What misconceptions about nutrition and obesity would you like to dispel among the general public?One only has to read the many malicious comments on social media: obesity is still perceived as a weakness, a lack of willpower. With the arrival of new drug treatments for obesity, I have the impression that this hostility is increasing: people are made to feel guilty, led to believe they are “stealing” medication from diabetics, or that they are seeking an easy solution.In reality, obesity is a chronic, complex, and multifactorial disease influenced by genetic, hormonal, psychological, social, and environmental factors. Reducing it to a statement such as “you just need to move more and eat less” is not only degrading but also medically incorrect.Another misconception is that following a strict diet, receiving injectable treatments, or undergoing surgery would be enough to solve the problem permanently. Since it is a chronic disease, one never truly recovers from it, and any weight loss induced by restrictive techniques will lead to yo-yo effects, frustration, guilt, and, in the long term, weight regain.For this reason, we always prioritize establishing the most balanced and sustainable daily eating habits possible, even if the theoretical ideal weight is not reached. The primary goal is to achieve an overall improvement in health, well-being, and quality of life. Contactez le Centre Intégré de l'Obésité Also read: Treating Obesity in 2026Professor Jean-Charles Preiser, from the Department of Internal Medicine and expert within the team of the Integrated Obesity Centre at H.U.B, explains the new approaches to managing this chronic disease. Read more Ingrid Hantson Dietitian accredited by the Federal Public Service for Public Health at the Integrated Obesity Center of H.U.B.

The Neurology Department of H.U.B is inaugurating today its brand-new Integrated Memory Clinic, dedicated to the care of people living with memory disorders or other cognitive impairments, including Alzheimer’s disease. Alzheimer’s disease: a major public health issue An estimated 200,000 to 220,000 persons in Belgium are at present living with a form of dementia or major neurocognitive disorder, Alzheimer’s disease being the most common cause (in 50% to 70% of cases). By 2050 the number of people living with such a disorder in Belgium is expected to be between 330,000 and 390,000, mainly due to the ageing population. In addition to the patients, thousands of loved ones and care workers are also affected, often facing a fragmented and complex care pathway. Meeting medical needs that remain insufficiently covered The Integrated Memory Clinic (CIMe) originated in an inescapable reality: patients with cognitive disorders require an  early assessment, a precise diagnosis and coordinated follow-up, covering medical, cognitive, functional and psychosocial dimensions. The H.U.B’s CIMe thus proposes a comprehensive and systemic patient pathway from the first consultation to long-term monitoring. At a single site a specialised and multidisciplinary team (neurologists, geriatricians, neuropsychologists, speech therapists, occupational therapists, specialised nurses) is at the service of the patients and their loved ones. Dr. Jean-Christophe Bier, Neurologist: “Our Integrated Memory Clinic enables us to improve monitoring, support and care for our patients and their families as effectively as possible while respecting their expectations and every specific situation, acting as  always at the forefront of science.”   A unique clinic by virtue of its integrated approach and leading edge technologies The Integrated Memory Clinic is distinctive for the way it integrates in the clinical routine  technologies that are rarely found within the same hospital structure: fully equipped observation rooms for the real time monitoring of neurological parameters (recordings day and night), Belgium’s only magnetoencephalography (MEG) machine and a unique virtual reality  chamber to assess patients in simulated environments that closely resemble their everyday environment. All of this at the heart of a pathway coordinated by a specialised multidisciplinary team.   This integrated approach permits a better understanding of cognitive disorders, a more personalised care and an improved patient experience. Clinical care and research: closely linked for the benefit of patientsThe Integrated Memory Clinic (CIMe) was also made possible thanks to the support it received from the Erasmus Fund, a committed partner of the H.U.B in developing innovative projects and in research.  Through this support the Erasmus Fund has helped finance clinical research projects pursued in tandem with care activity, including the “Remember” project that served to establish a large cohort of patients across the continuum of Alzheimer’s and associated neurodegenerative diseases with the aim of better defining the prognosis factors for the development of the disease. This research is part of the joint hospital-university dynamic that seeks to achieve progress in medical practices and include scientifically validated innovations more rapidly in patient care and treatment. Dr. Mélanie Strauss, Neurologist: “With the launch of the Integrated Memory Clinic and the support of the Erasmus Fund, we are building a reference centre combining clinical excellence and high level academic research so as to speed up discoveries and translate them directly into benefits for the patient.” An inauguration that looks to the futureWith the Integrated Memory Clinic the H.U.B’s  Department of Neurology is again placing its expertise in the service of treating complex pathologies and affirming its desire to provide a specific and innovative response to the challenges posed by Alzheimer’s disease and memory disorders by proposing individual and personalised pathways for each patient. Professor Nicolas Gaspard, Head of the Department of Neurology at the H.U.B:  “Thanks to the Integrated Memory Clinic and support from the Erasmus Fund, the H.U.B’s Department of Neurology is adopting a resolutely positive and bold approach to the future of neurodegenerative diseases.” CIMe - Contact & information

Our Clinic specializes in the diagnosis and management of movement disorders (including those caused by Parkinson’s disease). We offer a multidisciplinary approach, personalized follow-up, and access to advanced therapies. For specialized care of movement disorders Abnormal movements may result from various neurological, genetic, or metabolic diseases, may be related to certain medications or brain injuries, and are influenced by different risk factors. Their diagnosis and management therefore require specialized expertise to accurately identify the cause and adapt treatment in order to best preserve patients’ quality of life. Image Image Image Diagnosis and management of movement disorders We provide personalized care focused on quality of life and the patient’s goals through, among other things, a multidisciplinary approach integrating both motor and non-motor aspects (cognition, sleep, pain, mood, autonomy, etc.). When necessary, we refer patients to advanced therapies and specialized care pathways.  Personalized and multidisciplinary care Our comprehensive clinical assessment and longitudinal follow-up include the possibility of objectively tracking disease progression through clinical examinations, standardized scales, and even video recording when indicated. Movement disorders are not limited to motor symptoms; therefore, we pay special attention to non-motor symptoms and their impact on relatives. As a clinic within a leading university hospital, our academic expertise and our teaching and research activities directly benefit patients. Finally, our close collaboration with neurological rehabilitation within Erasmus Hospital allows us to offer optimal functional care and autonomy. Our care services Depending on the clinical situation, the Movement Disorders Clinic of the H.U.B offers:Specialized consultations (diagnosis, follow-up, and treatment adjustment)Assessment and management of:Parkinson’s disease and parkinsonian syndromesTremorsDystonia (involuntary muscle contractions causing abnormal postures or repetitive, sometimes painful movements)Chorea (rapid, jerky, unpredictable movements giving the impression the body is “dancing” involuntarily)TicsMyoclonus (sudden, very brief muscle jerks similar to involuntary startles)Gait and balance disorders (also called “ataxias”)Functional movement disordersEvaluation of complications (fluctuations, dyskinesia, pain, falls, autonomic nervous system disorders, sleep, anxiety, depression, fatigue, cognitive disorders, etc.)Referral to specific/advanced treatments when indicated (in collaboration with relevant teams):Botulinum toxin injectionsPump therapiesDeep brain stimulation (DBS)Coordination of multidisciplinary care (physiotherapy, speech therapy, occupational therapy, neuropsychology, etc.)Patient education and information: practical advice, reliable resources, information sessions Make an appointment Our team The team of the Movement Disorders Clinic of the H.U.B includes specialized physicians and multidisciplinary healthcare staff:Physiotherapist: Sara Ben ChekrounSpeech therapist: Sophie RobertNeuropsychologists: Hichem Slama and Christelle MaenhoutPsychologist: Véronique Simons Dr. Frédéric Supiot, Director of the Clinic Position: Neurologist, specialist in movement disordersConsults for Parkinson’s disease, tremors, dystonia, and other movement disordersPrincipal investigator in clinical research (Enroll HD program for Huntington’s disease)Performs botulinum toxin injections for certain movement disorders such as dystonia and hemispasmExpertise in DBS (deep brain stimulation) implantation and programmingExpertise in initiation, adjustment, and follow-up of patients treated with Duodopa pump therapy Dr. Virginie Destrebecq Position: Neurologist, specialist in movement disordersConsults for Parkinson’s disease, tremors, dystonia, and other movement disorders, as well as degenerative cerebellar diseases (ataxia) and functional neurological disordersReference specialist for rare ataxia diseases within the European network (ERN-RND)Principal investigator in clinical and cross-sectional research (essential tremor) Dr. Vincent Leclercq Position: Neurologist, specialist in movement disordersConsults for Parkinson’s disease, tremors, dystonia, and other movement disordersPays special attention to non-motor symptoms (behavioral disorders, mood disorders, sexual dysfunction, urinary and digestive disorders, pain, etc.)Promotes a global approach, with links to neurological rehabilitation when neededPerforms DBS programming and botulinum toxin injections Dr. Alexandra Boogers Position: Neurologist, specialist in movement disordersConsults for Parkinson’s disease, tremors, dystonia, and other movement disordersExpertise in DBS implantation and programming Services we collaborate with Neurology Lien vers Neurology Neurosurgery Lien vers Neurosurgery Radiology - Medical Imaging Lien vers Radiology - Medical Imaging As part of our collaboration with the Neurology Department, we regularly work with:Neurological Rehabilitation Unit (multidisciplinary rehabilitation)Sleep Unit (polysomnography)Clinical Neurophysiology Unit (recording of abnormal movements) FAQ on Parkinson’s disease and its management 1. What is Parkinson’s disease? Parkinson’s disease is a chronic neurological disorder associated with a progressive decrease in dopamine in certain regions of the brain. It can lead to motor symptoms (slowness, stiffness, tremor), but also non-motor symptoms (sleep disorders, fatigue, constipation, pain, anxiety, cognitive disorders, etc.). 2. What are the first symptoms of Parkinson’s disease? The first symptoms of Parkinson’s disease can be subtle and variable. The most common are:Slowness of movement (bradykinesia),Stiffness (rigidity),Resting tremor (not always present),Reduced arm swing when walking,Smaller handwriting (micrographia),Changes in voice,Non-motor symptoms such as constipation, loss of smell, sleep disorders (especially agitation during dreams), or unusual fatigue. 3. At what age does Parkinson’s disease begin? Parkinson’s disease most often begins after the age of 60, but it can also affect younger people. Early-onset Parkinson’s is defined when symptoms appear before the age of 50. The age of onset varies from one person to another and does not necessarily affect the severity of the disease. 4. What are the causes of Parkinson’s disease? The exact causes of Parkinson’s disease remain partially unknown. It results from a combination of genetic and environmental factors. In most cases, the disease is not hereditary. Exposure to certain pesticides or toxins is being studied as a possible risk factor. 5. How is Parkinson’s disease diagnosed? The diagnosis of Parkinson’s disease is primarily clinical. It is based on neurological examination and observation of symptoms. There is currently no single biological test. Additional examinations (brain MRI, dopaminergic scintigraphy) may be performed to rule out other diseases. 6. Is there a treatment for Parkinson’s disease? There is currently no curative treatment for Parkinson’s disease, but several treatments can effectively relieve symptoms. Dopaminergic medications, rehabilitation (physiotherapy, speech therapy), and in some cases deep brain stimulation significantly improve quality of life. 7. Is Parkinson’s disease hereditary? In the vast majority of cases, Parkinson’s disease is not hereditary. Only 5 to 10% of patients have an identified genetic form. Having a relative with the disease does not necessarily imply a high risk of developing it. 8. What is the life expectancy with Parkinson’s disease? The life expectancy of people with Parkinson’s disease is close to that of the general population, especially when the disease is well managed. Medical advances and multidisciplinary care have significantly improved prognosis and quality of life. 9. Can you live normally with Parkinson’s disease? Yes, it is possible to live a long and active life with Parkinson’s disease. Appropriate treatment, regular physical activity, medical support, and psychological support allow many people to maintain their independence and a satisfactory social life for many years. 10. Where can you find reliable information about Parkinson’s disease? For reliable information about Parkinson’s disease, it is recommended to consult:Your neurologist,Recognized patient associations,Institutional websites (university hospitals, scientific societies),Resources validated by healthcare professionals.

We are working to improve your app Important updates are currently being made to MyHUB: you may experience some disruption to access over the next few hours. Thank you for your patience; we are working to resolve all issues as soon as possible.